Leads Biolabs Advances Opamtistomig Toward Approval
NANJING, China, August 21, 2026 Nanjing Leads Biolabs Co., Ltd. announced that China’s Center for Drug Evaluation (CDE) under...
computational biology
Advertisement
Chai Discovery and BMS Advance AI Antibody Discovery
San Francisco, California, August 20, 2026 Chai Discovery has announced a collaboration with Bristol Myers Squibb (BMS) to advance...
Lantern Pharma Advances AI-Driven Drug Discovery Strategy
DALLAS, Aug. 14, 2026 Lantern Pharma Inc. is strengthening its position at the intersection of artificial intelligence and precision...
Apertura Reports Progress in AAV Gene Therapy for TSC1
SILVER SPRING, Md. and NEW YORK, July 30, 2026 The TSC Alliance and Apertura Gene Therapy have announced the...
Relation and GSK Expand $110M AI Drug Discovery Alliance
LONDON, July 30, 2026 Relation Therapeutics has announced an expanded strategic collaboration with GSK that will accelerate the use...
Advertisements
Levee Medical Completes ARID II Trial Enrollment for Voro
DURHAM, N.C., July 14, 2026 Levee Medical has reached a significant clinical development milestone with the successful completion of...
Chai Discovery Secures $400M to Transform AI Drug Discovery
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
Aureka Launches OpenDDE to Advance AI Drug Discovery
LAGUNA HILLS, California & SHANGHAI, China, July 6, 2026 Aureka, an AI TechBio company developing next-generation infrastructure for AI-driven...
Takeda Deploys Boltz AI Models to Accelerate Drug Discovery
CAMBRIDGE, Mass., June 20, 2026 Takeda and Boltz PBC have entered into a strategic collaboration aimed at accelerating the...
Incyte Expands AI Drug Discovery With Genesis
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
Advertisement
